Studies have shown that active fund managers routinely underperform the S&P500 index*​

Virax Biolabs Group Limited (VRAX) Stock Forecast 2027–2031

VRAX Price Today

$1.21

VRAX Stock Ratings

WSX Rating: STRONG SELL
Consensus Rating: NOT AVAILABLE

VRAX Price Targets

MonthCloseTotal,%
2026
Nov$1.210.00%
Dec$1.210.00%
2027
Jan$1.210.00%
Feb$1.19-1.65%
Mar$1.18-2.48%
Apr$1.18-2.48%
May$1.17-3.31%
Jun$1.15-4.96%
Jul$1.15-4.96%
Aug$1.13-6.61%
Sep$1.10-9.09%
Oct$1.09-9.92%
Nov$1.10-9.09%
Dec$1.09-9.92%
2028
Jan$1.09-9.92%
Feb$1.07-11.57%
Mar$1.06-12.40%
Apr$1.06-12.40%
May$1.05-13.22%
Jun$1.03-14.88%
Jul$1.03-14.88%
Aug$1.01-16.53%
Sep$0.99-18.18%
Oct$0.98-19.01%
Nov$0.98-19.01%
Dec$0.98-19.01%
2029
Jan$0.97-19.83%
Feb$0.95-21.49%
Mar$0.95-21.49%
Apr$0.94-22.31%
May$0.93-23.14%
Jun$0.91-24.79%
Jul$0.91-24.79%
Aug$0.89-26.45%
Sep$0.87-28.10%
Oct$0.86-28.93%
Nov$0.86-28.93%
Dec$0.86-28.93%
2030
Jan$0.85-29.75%
Feb$0.83-31.40%
Mar$0.83-31.40%
Apr$0.82-32.23%
May$0.81-33.06%
Jun$0.80-33.88%
Jul$0.79-34.71%
Aug$0.77-36.36%
Sep$0.75-38.02%
Oct$0.75-38.02%
Nov$0.74-38.84%
Dec$0.74-38.84%
2031
Jan$0.73-39.67%
Feb$0.72-40.50%
Mar$0.71-41.32%
Apr$0.70-42.15%
May$0.69-42.98%
Jun$0.68-43.80%
Jul$0.67-44.63%
Aug$0.66-45.45%
Sep$0.64-47.11%
Oct$0.63-47.93%

The VRAX stock price forecast for 2026 is $1.21, which is a change of +0.00% over today.

The VRAX stock price forecast for 2027 is $1.21, which is a change of +0.00% over today.

The VRAX stock price forecast for 2028 is $1.09, which is a change of -9.92% over today.

The VRAX stock price forecast for 2029 is $0.97, which is a change of -19.83% over today.

The VRAX stock price forecast for 2030 is $0.85, which is a change of -29.75% over today.

The VRAX stock price forecast for 2031 is $0.73, which is a change of -39.67% over today.

Is VRAX Stock a Buy?

Virax Biolabs Group Limited (VRAX) earns a STRONG SELL rating because its forecast indicates 9.92% price decline over the next 12 months, with market capitalization below $500 million limiting its rating to SELL or STRONG SELL. Its low revenue growth and high valuation inform the outlook, with elevated valuation remaining a key risk.

Is VRAX Stock a Good Long-Term Investment?

VRAX stock is not a good long-term investment because its sub-$500 million market capitalization and its STRONG SELL Wall Street X rating, high valuation and expected revenue growth of 0.00% warrant caution despite a final-year projection, with our models projecting a 2031 price of $0.73 (-39.67% compared to today’s price).

Can VRAX stock reach $200?

Our model is not projecting that VRAX will hit $200 within the five-year forecast, with its 2031 forecast reaching $0.73 (39.67% under today’s price).

VRAX Frequently Asked Questions

What is VRAX stock rated?

Wall Street X rates VRAX a STRONG SELL, and the average consensus rating is a NOT AVAILABLE.

Wall Street X has a one year price target of $1.09 for VRAX.

To buy shares of VRAX, open an account with an online brokerage, deposit money from your bank, search for “VRAX”, choose the number of shares or dollar amount, and place a trade.

Popular Articles

VRAX forecast data was last updated on by wallstreetx.com staff.

How Wall Street X Rates Stocks

Bookmark this page to check for updates:
on iPhone/iPad tap the Share icon Share. Select Add to Favorites, then Add.
on Android tap the 3-dots icon 3-dot at the top right. Tap Add to Favorites, then Add.
on PC press buttons Ctrl + D or click the star star next to the browser bar at the top.

Trending Stocks This Week

Loading…

JOIN OUR NEWSLETTER WAITLIST

Daily trending stocks, portfolio updates, upgrades/downgrades, and latest articles.

VRAX Price Target Calculator

Interactive calculator

Adjust growth and future valuation assumptions to estimate a stock price target.

Estimated target price$0.00
Potential return+0.0%
Current price supplied by your stock data
10.33%
Current multiple supplied by your stock data
Projected price by yearUSD
Stock forecastS&P 500 (10.4% annually)